Incyte Pulls Parsaclisib Files As FDA Takes Foot Off Accelerator

Was Seeking Accelerated Approval For PI3K inhibitor For Lymphoma

 
• By Kevin Grogan
  
red lights
FDA no longer keen on accelerated approval green lights • Source: Alamy

More from Anticancer

More from Therapy Areas